Promedior, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Promedior, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					        Promedior, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
       Reference Code: GDPH135528D                                                                                                           Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Promedior, Inc. (Promedior) is a biotechnology company, based in the US. The
                                                                                                              Promedior, Inc., Pharmaceuticals & Healthcare, Key
      company develops novel therapeutics for the treatment of fibrotic disorders and
                                                                                                              Facts
      diseases. Its pipeline of drug candidates includes PRM-151, PRM-167, inhaled,
      subcutaneous, and rhPTX-2 fusions. The company conducts research in detecting                            Web Address                      www.promedior.com
      and developing novel drugs for the treatment and prevention of fibrotic pathology. It
                                                                                                               Revenue (US$ million)                           NA
      provides PRM-151, a recombinant form of human pentraxin-2 protein formulated for
      intravenous or local injection. Promedior has collaboration and extramural research                      Number of Employees                             NA
      program apart from its drug discovery programs. The company was incorporated in                          GlobalData
      2006.

      Financial Deals Landscape
        Promedior, Inc., Pharmaceuticals & Healthcare, Deals by Type,                     Promedior, Inc., Pharmaceuticals & Healthcare, Deals By
        2007 to YTD 2013                                                                  Year, 2007 to YTD 2013


                                                                                                                          1              1      1        1
                                                                                                          1




                                                                                           No. of Deals

                                                                                                                 0                  0                              0
                                                                                                          0
                                                                                                               2007      2008    2009   2010   2011     2012   YTD
                                                                                                                                                               2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Promedior, Inc., Pharmaceuticals & Healthcare, Deals By                          Promedior, Inc., Pharmaceuticals & Healthcare, Deals By
         Region, 2007 to YTD 2013                                                         Therapy Area, 2007 to YTD 2013

                         5                                                                                5          4          4        4          4
                               4
          No. of Deals




                                                                                                                                                               3
                                                                                           No. of…




                                                                                                          4
                         4
                                                                                                          3
                         3                                                                                2
                         2                                                                                1
                                                                                                          0
                         1              0         0        0         0                                          Genito        Immun Metabol Ophthal Respira
                         0                                                                                      Urinary        ology    ic   mology  tory
                             North    Asia-     Europe   Middle   South                                         System               Disorde
                             Americ   Pacific             East     and                                           And                    rs
                               a                          and     Central                                         Sex
                                                         Africa   Americ                                        Hormo
                                                                    a                                             nes



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Promedior, Inc. - Pharmaceuticals & Healthcare - Deals and                                                                                     Reference Code: GDPH135528D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Promedior, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ......................................................................... 3
       Promedior, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 .......................................................................... 5
       Promedior, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ..................................................................... 6
       Promedior, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ........................................................... 7
       Promedior, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013....................................................................... 8
       Promedior, Inc., Pharmaceuticals & Healthcare, Deal Details ............................................................................................................ 9
          Venture Financing........................................................................................................................................................................... 9
             Promedior Raises $3 Million In Second Tranche Of Series D Financing..................................................................................... 9
             Promedior Secures $6.5 Million In Venture Financing............................................................................................................... 11
             Promedior Secures $12 Million In Series C Financing Round ................................................................................................... 12
             Promedior Secures Additional $7 Million In Series A Financing ................................................................................................ 14
       Promedior, Inc. - Key Competitors ................................................................................................................................................... 16
       Key Employees ................................................................................................................................................................................ 17
       Locations And Subsidiaries .............................................................................................................................................................. 18
          Head Office ................................................................................................................................................................................... 18
       Appendix .......................................................................................................................................................................................... 19
          Methodology ................................................................................................................................................................................. 19
          About GlobalData ......................................................................................................................................................................... 19
          Contact Us .................................................................................................................................................................................... 19
          Disclaimer ..................................................................................................................................................................................... 19




Promedior, Inc. - Pharmaceuticals & Healthcare
				
DOCUMENT INFO
Description: Promedior, Inc. (Promedior) is a biotechnology company, based in the US. The company develops novel therapeutics for the treatment of fibrotic disorders and diseases. Its pipeline of drug candidates includes PRM-151, PRM-167, inhaled, subcutaneous, and rhPTX-2 fusions. The company conducts research in detecting and developing novel drugs for the treatment and prevention of fibrotic pathology. It provides PRM-151, a recombinant form of human pentraxin-2 protein formulated for intravenous or local injection. Promedior has collaboration and extramural research program apart from its drug discovery programs. The company was incorporated in 2006. Promedior is headquartered in Malvern, Pennsylvania, the US.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.